Business Wire

Implanet Announces the Planned Divestment of Its Knee Prosthesis to Focus on Its Spine Business

BORDEAUX, France & BOSTON--(BUSINESS WIRE)--Regulatory News: IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME equity savings plans) a medical technology company specializing in ...
Nasdaq

IMPLANET Announces the First Surgical Procedures in the United States with JAZZ™ PF

JAZZ™ PF: a simple, innovative and proprietary addition to the JAZZ® range Addressable annual market of almost $350 million in the United States1 IMPLANET (Paris:ALIMP) (Euronext Growth: ALIMP, ...
Business Wire

IMPLANET Announces the Signature of a MOU on a Worldwide Partnership with Korean Company L&K BIOMED

BORDEAUX, France & BOSTON--(BUSINESS WIRE)--Regulatory News: IMPLANET (Paris:ALIMP) (OTCQX:IMPZY) (Euronext Growth: ALIMP, FR0010458729, PEA-PME eligible; OTCQX: IMPZY), a medical technology company ...
PharmiWeb

IMPLANET Receives FDA Clearance in the United States for the 3D Cage Range – Swingo™

IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME), a medical technology company specializing in implants for orthopedic surgery and the distribution of advanced medical equipment, ...
Morningstar

IMPLANET signs partnership agreement with 8i Robotics Inc. for the clinical evaluation of a surgeon-supervised robotic system for spine surgery | Morningstar

Ludovic Lastennet, IMPLANET’s Chief Executive Officer, stated: "As part of our strategic plan, the signing of this partnership agreement with 8i Robotics Inc., a Canadian manufacturer and innovative ...
Morningstar

IMPLANET Announces Financing of Around €2 Million

IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME equity savings plans), a medical technology company specializing in implants for orthopedic surgery and the distribution of ...
Seeking Alpha

IMPLANET Reports Revenue of €2.58 Million in Q1 2025, Up +16%

The Spine Implants business generated revenue of €2.11 million in Q1 2025, reflecting an 8% increase compared to the €1.96 million recorded in Q1 2024. The Company also continued to expand its medical ...
FierceBiotech

Implanet Announces the Appointment of Brian T. Ennis to Head Its US Subsidiary

BORDEAUX, France & BOSTON--(BUSINESS WIRE)--Regulatory News: IMPLANET (Euronext: IMPL, FR0010458729, PEA-PME eligible), a medical technology company specializing in vertebral and knee-surgery implants ...
PharmiWeb

IMPLANET Reports Full-Year 2025 Results

The Company generated revenue of €12.47 million for the 2025 financial year, compared with €9.41 million in 2024. The Spine Implants business recorded revenue of €8.57 million in 2025, compared with ...
Healio

Implanet receives FDA clearance and CE mark for new Jazz rods

Please provide your email address to receive an email when new articles are posted on . Implanet, a medical technology company specializing in vertebral and knee-surgery implants, recently announced ...
Yahoo Finance

IMPLANET signs partnership agreement with 8i Robotics Inc. for the clinical evaluation of a surgeon-supervised robotic system for spine surgery

BORDEAUX, France & BOSTON, November 13, 2025--(BUSINESS WIRE)--Regulatory News: IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME), a medical technology company specializing in ...